Aardvark Therapeutics, Inc. (AARD)
NASDAQ: AARD · Real-Time Price · USD
13.39
-0.47 (-3.39%)
Jun 27, 2025, 4:00 PM - Market closed
Aardvark Therapeutics Employees
Aardvark Therapeutics had 22 employees as of December 31, 2024.
Employees
22
Change
n/a
Growth
n/a
Revenue / Employee
n/a
Profits / Employee
-$1,260,000
Market Cap
290.51M
Employees Chart
Employees History
| Date | Employees | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 22 | - | - |
Related Stocks
| Company Name | Employees |
|---|---|
| UnitedHealth Group | 400,000 |
| Johnson & Johnson | 138,100 |
| Thermo Fisher Scientific | 125,000 |
| Abbott Laboratories | 114,000 |
| AstraZeneca | 94,300 |
| Novo Nordisk | 77,349 |
| Novartis AG | 75,883 |
| Merck & Co. | 75,000 |
AARD News
- 3 days ago - Aardvark Therapeutics to Join Prader-Willi Syndrome Community at the 2025 United in Hope Conference - GlobeNewsWire
- 5 weeks ago - Aardvark Therapeutics Bolsters Leadership Team with Strategic Hires Across Scientific, Commercial, Regulatory and Legal Functions - GlobeNewsWire
- 6 weeks ago - Aardvark Therapeutics Reports First Quarter 2025 Financial Results and Provides Business Highlights - GlobeNewsWire
- 7 weeks ago - Aardvark Therapeutics to Present at Upcoming Investor Conferences in May - GlobeNewsWire
- 3 months ago - Aardvark Therapeutics Reports Full Year 2024 Financial Results and Provides Business Highlights - GlobeNewsWire
- 4 months ago - U.S. IPO Weekly Recap: Big Listings Post Mixed Results In Busy 7 IPO Week - Seeking Alpha
- 4 months ago - Aardvark Therapeutics Announces Pricing of Initial Public Offering - GlobeNewsWire
- 4 months ago - U.S. IPO Weekly Recap: Cement And Cystic Fibrosis Drugs Lead A 6 IPO Week - Seeking Alpha